Disclosed are aminoacetonitrile derivatives AAD 450, AAD 907, AAD 970, AAD 1154, AAD 004, AAD 2009, AAD 1336 and AAD 1470 (as shown in drawing) that are useful in the treatment of cancer through kinase inhibition. Cancers include ovarian cancer, breast cancer, prostate cancer and mesothelioma.